{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:13:15Z","timestamp":1790057595414,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007780","name":"Indian Institute of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["F1-17.1\/2014-15\/RGNF-2014-15-ST-JHA-59310\/(SA-111)\/25\/02\/2015"],"award-info":[{"award-number":["F1-17.1\/2014-15\/RGNF-2014-15-ST-JHA-59310\/(SA-111)\/25\/02\/2015"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["SA-111"],"award-info":[{"award-number":["SA-111"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["0020"],"award-info":[{"award-number":["0020"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005231","name":"CAS-SAFEA International Partnership Program for Creative Research Teams","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005808","name":"Indian Institute of Technology Bombay","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005739","name":"Indiana Space Grant Consortium","doi-asserted-by":"publisher","award":["7LCTOIERI004"],"award-info":[{"award-number":["7LCTOIERI004"]}],"id":[{"id":"10.13039\/100005739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.biopha.2017.08.071","type":"journal-article","created":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T10:46:13Z","timestamp":1505213173000},"page":"402-411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Effect of two andrographolide derivatives on cellular and rodent models of non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"95","author":[{"given":"Erenius","family":"Toppo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Sylvester","family":"Darvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Esakkimuthu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh Kumar","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Balakrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Sivasankaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Pandikumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ignacimuthu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.A.","family":"Al-Dhabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.08.071_bib0005","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cgh.2008.11.005","article-title":"Long-term follow-up of patients with nonalcoholic fatty liver","volume":"7","author":"Rafiq","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2017.08.071_bib0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2017.08.071_bib0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jceh.2015.02.006","article-title":"Non-alcoholic fatty liver disease and metabolic syndrome \u2212 position paper of the indian national association for the study of the liver, endocrine society of India, indian college of cardiology and indian society of gastroenterology","volume":"5","author":"Duseja","year":"2015","journal-title":"J. Clin. Expt. Hepatol."},{"key":"10.1016\/j.biopha.2017.08.071_bib0020","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2017.08.071_bib0025","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jada.2011.10.007","article-title":"The role of diet and nutrient composition in nonalcoholic Fatty liver disease","volume":"112","author":"McCarthy","year":"2012","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/j.biopha.2017.08.071_bib0030","first-page":"447","article-title":"Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment","volume":"111","author":"Weib","year":"2014","journal-title":"Deutsches \u00c4rzteblatt Int."},{"key":"10.1016\/j.biopha.2017.08.071_bib0035","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/648308","article-title":"Herbal medicines for the treatment of nonalcoholic steatohepatitis: current scenario and future prospects","author":"Jadeja","year":"2014","journal-title":"J. Evid. Based Complement. Altern. Med."},{"issue":"1","key":"10.1016\/j.biopha.2017.08.071_bib0040","first-page":"41","article-title":"Hepatoprotective and antioxidant property of Andrographis paniculata (Nees) in BHC induced liver damage in mice","volume":"39","author":"Trivedi","year":"2001","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.biopha.2017.08.071_bib0045","first-page":"S41","article-title":"Effect of Andrographis paniculata extract on triglyceride levels of the patients with hypertriglyceridemia: a randomized controlled trial","volume":"98","author":"Phunikhom","year":"2015","journal-title":"J. Med. Assoc. Thai."},{"issue":"1","key":"10.1016\/j.biopha.2017.08.071_bib0050","first-page":"66","article-title":"Andrographis paniculata: a review of pharmacological activities and clinical effects","volume":"16","author":"Akbar","year":"2011","journal-title":"Altern. Med. Rev."},{"issue":"11","key":"10.1016\/j.biopha.2017.08.071_bib0055","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/ptr.5193","article-title":"Review on liver inflammation and antiinflammatory activity of Andrographis paniculata for hepatoprotection","volume":"28","author":"Chua","year":"2014","journal-title":"Phytother. Res."},{"issue":"2","key":"10.1016\/j.biopha.2017.08.071_bib0060","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1124\/jpet.114.217968","article-title":"Andrographolide prevents high-fat diet-induced obesity in C57BL\/6 mice by suppressing the sterol regulatory element-binding protein pathway","volume":"351","author":"Ding","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2017.08.071_bib0065","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1517\/13543776.2012.661718","article-title":"Modifications of andrographolide to increase some biological activities: a patent review (2006\u2013011)","volume":"22","author":"Aromdee","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"issue":"10","key":"10.1016\/j.biopha.2017.08.071_bib0070","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1517\/13543776.2014.956084","article-title":"Andrographolide: progression in its modifications and applications \u2212 a patent review (2012\u20132014)","volume":"24","author":"Aromdee","year":"2014","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.biopha.2017.08.071_bib0075","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/157340612800493629","article-title":"Synthesis and preliminary antihyperlipidaemic activities evaluation of andrographolide derivatives","volume":"8","author":"Wang","year":"2012","journal-title":"Med. Chem."},{"key":"10.1016\/j.biopha.2017.08.071_bib0080","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejmech.2013.09.002","article-title":"Synthesis of new andrographolide derivatives and evaluation of their antidyslipidemic: LDL-oxidation and antioxidant activity","volume":"69","author":"Pandeti","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2017.08.071_bib0085","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/cbdd.12246","article-title":"Design, synthesis, and biological evaluation of andrographolide derivatives as potent hepatoprotective agents","volume":"83","author":"Tang","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.biopha.2017.08.071_bib0090","first-page":"298","article-title":"Biological activities and corresponding SARs of andrographolide and its derivatives","volume":"13","author":"Zhou","year":"2013","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.biopha.2017.08.071_bib0095","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.bmcl.2014.03.060","article-title":"Synthesis: structure-activity relationships and biological evaluation of dehydroandrographolide and andrographolide derivatives as novel anti-hepatitis B virus agents","volume":"24","author":"Chen","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"10","key":"10.1016\/j.biopha.2017.08.071_bib0100","first-page":"747","article-title":"Purification (Crystallization) of bioactive ingredient andgrographolide from Andrographis paniculata","volume":"3","author":"Jadhao","year":"2014","journal-title":"World J. Pharm. Pharmacy Sci."},{"issue":"9","key":"10.1016\/j.biopha.2017.08.071_bib0105","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s12272-009-1902-x","article-title":"Analgesic, antipyretic, anti-inflammatory and toxic effect of andrographolide derivatives in experimental animals","volume":"32","author":"Suebsasana","year":"2009","journal-title":"Arch. Pharm. Res."},{"issue":"6","key":"10.1016\/j.biopha.2017.08.071_bib0110","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1248\/cpb.42.1216","article-title":"Cell differentiation inducing diterpenes from Andrographis paniculata Nees","volume":"42","author":"Matsuda","year":"1994","journal-title":"Chem Pharm. Bull."},{"issue":"4","key":"10.1016\/j.biopha.2017.08.071_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0152770","article-title":"Development of a bifunctional Andrographolide \u2212 based chemical probe for pharmacological study","volume":"11","author":"Hsu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.08.071_bib0120","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/ci500588j","article-title":"DataWarrior: an open-source program for chemistry aware data visualization and analysis","volume":"55","author":"Sander","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.biopha.2017.08.071_bib0125","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.biopha.2017.08.071_bib0130","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1159\/000447866","article-title":"Differential lipotoxic effects of palmitate and oleate in activated human hepatic stellate cells and epithelial hepatoma cells","volume":"39","author":"Hetherington","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.biopha.2017.08.071_bib0135","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa060326","article-title":"A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis","volume":"355","author":"Belfort","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.biopha.2017.08.071_bib0140","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/BF00316069","article-title":"Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O","volume":"97","author":"Ramirez-Zacarias","year":"1992","journal-title":"Histochem"},{"key":"10.1016\/j.biopha.2017.08.071_bib0145","first-page":"1","article-title":"Primary observation (Irwin) test in rodents for assessing acute toxicity of a test agent and its effect on behavior and physiological function","volume":"10","author":"Roux","year":"2004","journal-title":"Curr. Protocol Pharmacol."},{"key":"10.1016\/j.biopha.2017.08.071_bib0150","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejphar.2016.07.032","article-title":"Effects of andrographolide on intrahepatic cholestasis induced by alpha-naphthylisothiocyanate in rats","volume":"789","author":"Khamphaya","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.08.071_bib0155","doi-asserted-by":"crossref","first-page":"e86724","DOI":"10.1371\/journal.pone.0086724","article-title":"Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced Non-Alcoholic Fatty Liver Disease Rats","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.08.071_bib0160","first-page":"2683","article-title":"Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL\/6 mice","volume":"6","author":"Itagaki","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.biopha.2017.08.071_bib0165","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1021\/np050211n","article-title":"Androponolide and Isoandrographolide, minor diterpenoids from Andrographis paniculata: structure and X-ray crystallographic analysis","volume":"69","author":"Pramanick","year":"2006","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2017.08.071_bib0170","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisted","volume":"22","author":"Reagan-Shaw","year":"2007","journal-title":"FASEB J."},{"issue":"22","key":"10.1016\/j.biopha.2017.08.071_bib0175","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"J. Am. Med. Assoc."},{"issue":"3","key":"10.1016\/j.biopha.2017.08.071_bib0180","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.26717","article-title":"Extrahepatic complications of nonalcoholic fatty liver disease","volume":"59","author":"Armstrong","year":"2014","journal-title":"Hepatol"},{"issue":"1","key":"10.1016\/j.biopha.2017.08.071_bib0185","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/hep.22575","article-title":"Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial","volume":"49","author":"Harrison","year":"2009","journal-title":"Hepatol"},{"issue":"3","key":"10.1016\/j.biopha.2017.08.071_bib0190","first-page":"258","article-title":"Medical nutrition therapy in non-alcoholic fatty liver disease \u2212a review of literature","volume":"8","author":"Rusu","year":"2015","journal-title":"J. Med. Life."},{"key":"10.1016\/j.biopha.2017.08.071_bib0195","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/flgastro-2013-100404","article-title":"Non-alcoholic fatty liver disease: a practical approach to treatment","volume":"5","author":"Dyson","year":"2014","journal-title":"Frontline Gastroenterol."},{"issue":"2","key":"10.1016\/j.biopha.2017.08.071_bib0200","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4103\/2225-4110.110411","article-title":"Recent advances in the herbal treatment of non-alcoholic Fatty liver disease","volume":"3","author":"Xiao","year":"2013","journal-title":"J. Tradit. Complement. Med"},{"key":"10.1016\/j.biopha.2017.08.071_bib0205","first-page":"CD009059","article-title":"Herbal medicines for fatty liver diseases","volume":"8","author":"Liu","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.biopha.2017.08.071_bib0210","doi-asserted-by":"crossref","first-page":"e58055","DOI":"10.1371\/journal.pone.0058055","article-title":"Cytotoxic activity and apoptosis-inducing potential of di-spiropyrrolidino and di-spiropyrrolizidino oxindole andrographolide derivatives","volume":"8","author":"Dey","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.08.071_bib0215","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2174\/157018010790596614","article-title":"Synthesis and preliminary COX-2 expression inhibitory activities of andrographolide derivatives","volume":"7","author":"Li","year":"2010","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.biopha.2017.08.071_bib0220","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3892\/ijmm.2016.2674","article-title":"Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor \u03b3","volume":"38","author":"Tsujimoto","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2017.08.071_bib0225","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2174\/138920112799095310","article-title":"Methodologies for investigating natural medicines for the treatment of nonalcoholic fatty liver disease (NAFLD)","volume":"13","author":"Kim","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.biopha.2017.08.071_bib0230","doi-asserted-by":"crossref","first-page":"S627","DOI":"10.33549\/physiolres.933224","article-title":"The Effect of oleic and palmitic acid on induction of steatosis and cytotoxicity on rat hepatocytes in primary culture","volume":"64","author":"Moravcova","year":"2015","journal-title":"Physiol. Res."},{"issue":"3","key":"10.1016\/j.biopha.2017.08.071_bib0235","first-page":"284","article-title":"Lipotoxicity in HepG2 cells triggered by free fatty acids","volume":"3","author":"Yao","year":"2011","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.biopha.2017.08.071_bib0240","first-page":"61","article-title":"Overview of animal models of obesity","volume":"5","author":"Lutz","year":"2012","journal-title":"Curr. Protoc. Pharmacol."},{"issue":"11","key":"10.1016\/j.biopha.2017.08.071_bib0245","doi-asserted-by":"crossref","first-page":"21240","DOI":"10.3390\/ijms141121240","article-title":"Lessons from mouse models of high-fat diet-induced NAFLD","volume":"14","author":"Nakamura","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2017.08.071_bib0250","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1478-3231.2008.01718.x","article-title":"Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus","volume":"29","author":"Leite","year":"2009","journal-title":"Liver Int."},{"issue":"5","key":"10.1016\/j.biopha.2017.08.071_bib0255","first-page":"712","article-title":"Is liver transaminases assessment an appropriate tool for the screening of non-alcoholic fatty liver disease in at risk obese children and adolescents?","volume":"25","author":"Rodriguez","year":"2010","journal-title":"Nutr. Hosp."},{"key":"10.1016\/j.biopha.2017.08.071_bib0260","first-page":"g4596","article-title":"Non-alcoholic fatty liver disease","volume":"349","author":"Sattar","year":"2014","journal-title":"BrMedJ"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217325994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217325994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:46:57Z","timestamp":1771400817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217325994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":52,"alternative-id":["S0753332217325994"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.08.071","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of two andrographolide derivatives on cellular and rodent models of non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.08.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}